Advanced Search

    Technical Analysis for AMLX - Amylyx Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 28.74 -1.03% -0.30
    AMLX closed down 1.03 percent on Friday, March 24, 2023, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical AMLX trend table...
    Date Alert Name Type % Chg
    Doji - Bullish? Reversal 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction -1.03%
    NR7-2 Range Contraction -1.03%
    Lower Bollinger Band Walk Weakness -1.03%
    Down 3 Days in a Row Weakness -1.03%
    Older End-of-Day Signals for AMLX ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Lower Bollinger Band Support about 10 hours ago
    Down 3% about 15 hours ago
    Fell Below Lower Bollinger Band about 15 hours ago
    Fell Below Previous Day's Low about 15 hours ago
    Down 2 % about 15 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators Basic chart:

    Profile

    Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada. The company is developing AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and tauroursodeoxycholic acid for the treatment of ALS and other neurodegenerative diseases. It is also developing products for Wolfram syndrome and Alzheimer's diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Pharmaceutical Alzheimer's Disease Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Nervous System Apoptosis Neurodegenerative Disease

    Is AMLX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 18 Party Time: Brokers Just Made Major Increases To Their Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Earnings Forecasts
    Mar 15 Amylyx Pharmaceuticals (NASDAQ:AMLX) shareholders are still up 49% over 1 year despite pulling back 5.5% in the past week
    Mar 14 Why Amylyx Pharmaceuticals Stock Is Bolting Higher Today
    Mar 14 Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2022 Earnings Call Transcript
    Mar 14 Hot Stocks: FRC, WAL, KEY rebound; BG higher on replacing SBNY in S&P 500; NTCO, GTLB, BZFD slide on earnings
    Mar 14 Amylyx, A Top 5% Biotech Stock, Just Scored A Huge Win In ALS Treatment
    Mar 14 Q4 2022 Amylyx Pharmaceuticals Inc Earnings Call
    Mar 13 Amylyx Pharmaceuticals, Inc. (AMLX) Q4 2022 Earnings Call Transcript
    Mar 13 Amylx Pharmaceuticals jumps 20% on Q4 top and bottom line beats
    Mar 13 Amylyx Pharmaceuticals GAAP EPS of -$0.65 beats by $0.16, revenue of $21.89M beats by $17.17M
    See more AMLX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 41.92
    52 Week Low 6.51
    Average Volume 957,183
    200-Day Moving Average 30.56
    50-Day Moving Average 35.09
    20-Day Moving Average 32.56
    10-Day Moving Average 31.03
    Average True Range 2.24
    RSI 35.90
    ADX 13.12
    +DI 19.86
    -DI 30.46
    Chandelier Exit (Long, 3 ATRs) 31.59
    Chandelier Exit (Short, 3 ATRs) 34.36
    Upper Bollinger Bands 37.01
    Lower Bollinger Band 28.11
    Percent B (%b) 0.07
    BandWidth 27.34
    MACD Line -1.61
    MACD Signal Line -1.23
    MACD Histogram -0.3891
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 31.04
    Resistance 3 (R3) 30.92 30.04 30.65
    Resistance 2 (R2) 30.04 29.46 30.10 30.52
    Resistance 1 (R1) 29.39 29.09 28.95 29.51 30.40
    Pivot Point 28.51 28.51 28.29 28.57 28.51
    Support 1 (S1) 27.86 27.93 27.42 27.98 27.08
    Support 2 (S2) 26.98 27.56 27.04 26.96
    Support 3 (S3) 26.33 26.98 26.83
    Support 4 (S4) 26.45